A significantly greater number of CD8+ CTLs, and significantly fewer FoxP3+ Tregs, were found in tumors of the groups receiving the cytokine gene transduction and DC treatment, which yielded significantly better results in tumor therapy (Figures 5 and 6). Here, CD8A is linked to neoplasm.